nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2D6—breast cancer	0.109	0.538	CbGaD
Mirtazapine—CYP3A4—breast cancer	0.0931	0.462	CbGaD
Mirtazapine—HTR2B—Raloxifene—breast cancer	0.0535	0.128	CbGbCtD
Mirtazapine—CYP1A2—Anastrozole—breast cancer	0.0251	0.06	CbGbCtD
Mirtazapine—CYP1A2—Toremifene—breast cancer	0.0229	0.0549	CbGbCtD
Mirtazapine—CYP2C9—Anastrozole—breast cancer	0.0226	0.0541	CbGbCtD
Mirtazapine—CYP2C8—Lapatinib—breast cancer	0.0216	0.0517	CbGbCtD
Mirtazapine—CYP3A4—Exemestane—breast cancer	0.0173	0.0415	CbGbCtD
Mirtazapine—CYP2C9—Idarubicin—breast cancer	0.0171	0.041	CbGbCtD
Mirtazapine—CYP2C8—Raloxifene—breast cancer	0.0164	0.0392	CbGbCtD
Mirtazapine—CYP2D6—Idarubicin—breast cancer	0.0156	0.0375	CbGbCtD
Mirtazapine—CYP3A4—Letrozole—breast cancer	0.0147	0.0353	CbGbCtD
Mirtazapine—CYP3A4—Anastrozole—breast cancer	0.0131	0.0315	CbGbCtD
Mirtazapine—CYP3A4—Toremifene—breast cancer	0.012	0.0288	CbGbCtD
Mirtazapine—CYP3A4—Fulvestrant—breast cancer	0.0112	0.0267	CbGbCtD
Mirtazapine—CYP2C8—Tamoxifen—breast cancer	0.0108	0.0259	CbGbCtD
Mirtazapine—CYP3A4—Thiotepa—breast cancer	0.00995	0.0238	CbGbCtD
Mirtazapine—CYP2C9—Capecitabine—breast cancer	0.00938	0.0225	CbGbCtD
Mirtazapine—CYP3A4—Ixabepilone—breast cancer	0.0091	0.0218	CbGbCtD
Mirtazapine—CYP3A4—Lapatinib—breast cancer	0.00876	0.021	CbGbCtD
Mirtazapine—CYP2C8—Paclitaxel—breast cancer	0.00842	0.0202	CbGbCtD
Mirtazapine—CYP1A2—Tamoxifen—breast cancer	0.00837	0.0201	CbGbCtD
Mirtazapine—CYP2C8—Fluorouracil—breast cancer	0.00797	0.0191	CbGbCtD
Mirtazapine—CYP2D6—Vinorelbine—breast cancer	0.00764	0.0183	CbGbCtD
Mirtazapine—CYP2C9—Tamoxifen—breast cancer	0.00754	0.0181	CbGbCtD
Mirtazapine—CYP2D6—Tamoxifen—breast cancer	0.0069	0.0165	CbGbCtD
Mirtazapine—CYP3A4—Raloxifene—breast cancer	0.00664	0.0159	CbGbCtD
Mirtazapine—CYP1A2—Fluorouracil—breast cancer	0.00617	0.0148	CbGbCtD
Mirtazapine—CYP2C9—Paclitaxel—breast cancer	0.00587	0.0141	CbGbCtD
Mirtazapine—CYP2C9—Fluorouracil—breast cancer	0.00556	0.0133	CbGbCtD
Mirtazapine—CYP3A4—Vinorelbine—breast cancer	0.00486	0.0116	CbGbCtD
Mirtazapine—CYP2D6—Vinblastine—breast cancer	0.00471	0.0113	CbGbCtD
Mirtazapine—CYP3A4—Tamoxifen—breast cancer	0.00439	0.0105	CbGbCtD
Mirtazapine—CYP3A4—Mitoxantrone—breast cancer	0.00428	0.0102	CbGbCtD
Mirtazapine—CYP3A4—Paclitaxel—breast cancer	0.00341	0.00818	CbGbCtD
Mirtazapine—CYP3A4—Irinotecan—breast cancer	0.00337	0.00807	CbGbCtD
Mirtazapine—CYP3A4—Vinblastine—breast cancer	0.00299	0.00717	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—breast cancer	0.00289	0.00693	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—breast cancer	0.00247	0.00591	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—breast cancer	0.00184	0.00441	CbGbCtD
Mirtazapine—CYP2C8—mammary gland—breast cancer	0.000469	0.0276	CbGeAlD
Mirtazapine—OPRK1—female reproductive system—breast cancer	0.000454	0.0267	CbGeAlD
Mirtazapine—ADRA2C—nipple—breast cancer	0.000419	0.0246	CbGeAlD
Mirtazapine—CYP2C9—mammary gland—breast cancer	0.000417	0.0245	CbGeAlD
Mirtazapine—CYP1A2—nipple—breast cancer	0.000363	0.0214	CbGeAlD
Mirtazapine—HTR2B—skin of body—breast cancer	0.000341	0.02	CbGeAlD
Mirtazapine—HRH1—nipple—breast cancer	0.00034	0.02	CbGeAlD
Mirtazapine—ADRA2A—nipple—breast cancer	0.000334	0.0196	CbGeAlD
Mirtazapine—HTR2B—endometrium—breast cancer	0.000321	0.0189	CbGeAlD
Mirtazapine—HTR7—epithelium—breast cancer	0.000307	0.018	CbGeAlD
Mirtazapine—ADRB1—adipose tissue—breast cancer	0.000302	0.0178	CbGeAlD
Mirtazapine—HTR2B—uterus—breast cancer	0.000296	0.0174	CbGeAlD
Mirtazapine—ADRA1A—epithelium—breast cancer	0.000296	0.0174	CbGeAlD
Mirtazapine—HTR2B—adipose tissue—breast cancer	0.000289	0.017	CbGeAlD
Mirtazapine—HTR2C—female reproductive system—breast cancer	0.000283	0.0167	CbGeAlD
Mirtazapine—ADRB1—female reproductive system—breast cancer	0.000278	0.0163	CbGeAlD
Mirtazapine—SLC6A4—female reproductive system—breast cancer	0.000268	0.0158	CbGeAlD
Mirtazapine—HTR2B—female reproductive system—breast cancer	0.000266	0.0156	CbGeAlD
Mirtazapine—HTR2B—adrenal gland—breast cancer	0.00026	0.0153	CbGeAlD
Mirtazapine—ADRA2C—endometrium—breast cancer	0.000253	0.0149	CbGeAlD
Mirtazapine—ADRA1A—adipose tissue—breast cancer	0.000239	0.0141	CbGeAlD
Mirtazapine—SLC6A2—female reproductive system—breast cancer	0.000236	0.0139	CbGeAlD
Mirtazapine—DRD2—pituitary gland—breast cancer	0.000235	0.0138	CbGeAlD
Mirtazapine—ADRB1—endocrine gland—breast cancer	0.000235	0.0138	CbGeAlD
Mirtazapine—CYP2C8—endometrium—breast cancer	0.000234	0.0138	CbGeAlD
Mirtazapine—HTR2A—embryo—breast cancer	0.000234	0.0138	CbGeAlD
Mirtazapine—ADRA2C—uterus—breast cancer	0.000233	0.0137	CbGeAlD
Mirtazapine—HTR1A—adrenal gland—breast cancer	0.000233	0.0137	CbGeAlD
Mirtazapine—SLC6A2—adrenal gland—breast cancer	0.000231	0.0136	CbGeAlD
Mirtazapine—HRH1—epithelium—breast cancer	0.000229	0.0135	CbGeAlD
Mirtazapine—ADRA2C—pituitary gland—breast cancer	0.000229	0.0134	CbGeAlD
Mirtazapine—HTR7—female reproductive system—breast cancer	0.000228	0.0134	CbGeAlD
Mirtazapine—ADRA2C—adipose tissue—breast cancer	0.000228	0.0134	CbGeAlD
Mirtazapine—SLC6A4—endocrine gland—breast cancer	0.000227	0.0134	CbGeAlD
Mirtazapine—HTR7—adrenal gland—breast cancer	0.000222	0.0131	CbGeAlD
Mirtazapine—ADRA1A—adrenal gland—breast cancer	0.000214	0.0126	CbGeAlD
Mirtazapine—CYP2C8—pituitary gland—breast cancer	0.000212	0.0125	CbGeAlD
Mirtazapine—Azatadine—CYP3A4—breast cancer	0.000208	0.289	CrCbGaD
Mirtazapine—HRH1—endometrium—breast cancer	0.000205	0.0121	CbGeAlD
Mirtazapine—ADRA2C—adrenal gland—breast cancer	0.000204	0.012	CbGeAlD
Mirtazapine—HTR1A—endocrine gland—breast cancer	0.000202	0.0119	CbGeAlD
Mirtazapine—ADRA2A—endometrium—breast cancer	0.000202	0.0119	CbGeAlD
Mirtazapine—SLC6A2—endocrine gland—breast cancer	0.0002	0.0118	CbGeAlD
Mirtazapine—CYP2C8—female reproductive system—breast cancer	0.000194	0.0114	CbGeAlD
Mirtazapine—HTR7—endocrine gland—breast cancer	0.000193	0.0113	CbGeAlD
Mirtazapine—HTR2A—epithelium—breast cancer	0.000191	0.0112	CbGeAlD
Mirtazapine—ADRA2C—female gonad—breast cancer	0.00019	0.0112	CbGeAlD
Mirtazapine—ADRA1A—endocrine gland—breast cancer	0.000186	0.0109	CbGeAlD
Mirtazapine—ADRA2A—uterus—breast cancer	0.000186	0.0109	CbGeAlD
Mirtazapine—HRH1—adipose tissue—breast cancer	0.000185	0.0109	CbGeAlD
Mirtazapine—ADRA2A—pituitary gland—breast cancer	0.000182	0.0107	CbGeAlD
Mirtazapine—DRD2—endocrine gland—breast cancer	0.000182	0.0107	CbGeAlD
Mirtazapine—ADRA2A—adipose tissue—breast cancer	0.000182	0.0107	CbGeAlD
Mirtazapine—CYP2C9—female reproductive system—breast cancer	0.000172	0.0101	CbGeAlD
Mirtazapine—HRH1—female reproductive system—breast cancer	0.00017	0.01	CbGeAlD
Mirtazapine—ADRA2A—female reproductive system—breast cancer	0.000167	0.00982	CbGeAlD
Mirtazapine—HRH1—adrenal gland—breast cancer	0.000166	0.00976	CbGeAlD
Mirtazapine—CYP2C8—endocrine gland—breast cancer	0.000164	0.00966	CbGeAlD
Mirtazapine—ADRA2A—adrenal gland—breast cancer	0.000163	0.00959	CbGeAlD
Mirtazapine—HTR2B—lymph node—breast cancer	0.000156	0.00915	CbGeAlD
Mirtazapine—HTR2A—pituitary gland—breast cancer	0.000155	0.00912	CbGeAlD
Mirtazapine—HRH1—female gonad—breast cancer	0.000155	0.0091	CbGeAlD
Mirtazapine—CYP1A2—endocrine gland—breast cancer	0.000154	0.00904	CbGeAlD
Mirtazapine—ADRA2A—female gonad—breast cancer	0.000152	0.00894	CbGeAlD
Mirtazapine—CYP2C9—endocrine gland—breast cancer	0.000146	0.00858	CbGeAlD
Mirtazapine—HRH1—endocrine gland—breast cancer	0.000144	0.00846	CbGeAlD
Mirtazapine—HTR2A—female reproductive system—breast cancer	0.000142	0.00835	CbGeAlD
Mirtazapine—ADRA2A—endocrine gland—breast cancer	0.000141	0.00831	CbGeAlD
Mirtazapine—Epinastine—CYP2D6—breast cancer	0.00014	0.195	CrCbGaD
Mirtazapine—HTR2A—adrenal gland—breast cancer	0.000139	0.00815	CbGeAlD
Mirtazapine—SLC6A2—lymph node—breast cancer	0.000138	0.00813	CbGeAlD
Mirtazapine—CYP3A4—female reproductive system—breast cancer	0.000131	0.00773	CbGeAlD
Mirtazapine—CYP2D6—female reproductive system—breast cancer	0.000129	0.00761	CbGeAlD
Mirtazapine—ADRA2C—lymph node—breast cancer	0.000122	0.0072	CbGeAlD
Mirtazapine—Epinastine—CYP3A4—breast cancer	0.00012	0.167	CrCbGaD
Mirtazapine—HTR2A—endocrine gland—breast cancer	0.00012	0.00707	CbGeAlD
Mirtazapine—CYP2D6—female gonad—breast cancer	0.000118	0.00692	CbGeAlD
Mirtazapine—CYP3A4—endocrine gland—breast cancer	0.000111	0.00654	CbGeAlD
Mirtazapine—CYP2D6—endocrine gland—breast cancer	0.00011	0.00644	CbGeAlD
Mirtazapine—Epinastine—ABCB1—breast cancer	0.0001	0.139	CrCbGaD
Mirtazapine—HRH1—lymph node—breast cancer	9.95e-05	0.00585	CbGeAlD
Mirtazapine—ADRA2A—lymph node—breast cancer	9.77e-05	0.00575	CbGeAlD
Mirtazapine—Mianserin—CYP2D6—breast cancer	8.13e-05	0.113	CrCbGaD
Mirtazapine—Mianserin—CYP3A4—breast cancer	6.97e-05	0.0967	CrCbGaD
Mirtazapine—Insomnia—Capecitabine—breast cancer	2.79e-05	0.000115	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—breast cancer	2.78e-05	0.000115	CcSEcCtD
Mirtazapine—Rash—Fluorouracil—breast cancer	2.78e-05	0.000115	CcSEcCtD
Mirtazapine—Dermatitis—Fluorouracil—breast cancer	2.78e-05	0.000114	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—breast cancer	2.77e-05	0.000114	CcSEcCtD
Mirtazapine—Paraesthesia—Capecitabine—breast cancer	2.77e-05	0.000114	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—breast cancer	2.77e-05	0.000114	CcSEcCtD
Mirtazapine—Hypersensitivity—Paclitaxel—breast cancer	2.77e-05	0.000114	CcSEcCtD
Mirtazapine—Headache—Fluorouracil—breast cancer	2.76e-05	0.000114	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—breast cancer	2.76e-05	0.000114	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—breast cancer	2.75e-05	0.000113	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—breast cancer	2.75e-05	0.000113	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—breast cancer	2.75e-05	0.000113	CcSEcCtD
Mirtazapine—Dyspnoea—Capecitabine—breast cancer	2.75e-05	0.000113	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—breast cancer	2.74e-05	0.000113	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—breast cancer	2.74e-05	0.000113	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—breast cancer	2.74e-05	0.000113	CcSEcCtD
Mirtazapine—Nausea—Irinotecan—breast cancer	2.73e-05	0.000113	CcSEcCtD
Mirtazapine—Nausea—Mitoxantrone—breast cancer	2.73e-05	0.000113	CcSEcCtD
Mirtazapine—Pain—Docetaxel—breast cancer	2.72e-05	0.000112	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—breast cancer	2.72e-05	0.000112	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—breast cancer	2.72e-05	0.000112	CcSEcCtD
Mirtazapine—Dyspepsia—Capecitabine—breast cancer	2.71e-05	0.000112	CcSEcCtD
Mirtazapine—Chills—Epirubicin—breast cancer	2.71e-05	0.000112	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—breast cancer	2.7e-05	0.000111	CcSEcCtD
Mirtazapine—Asthenia—Paclitaxel—breast cancer	2.69e-05	0.000111	CcSEcCtD
Mirtazapine—Decreased appetite—Capecitabine—breast cancer	2.68e-05	0.00011	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—breast cancer	2.67e-05	0.00011	CcSEcCtD
Mirtazapine—Nausea—Gemcitabine—breast cancer	2.66e-05	0.00011	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Capecitabine—breast cancer	2.66e-05	0.00011	CcSEcCtD
Mirtazapine—Fatigue—Capecitabine—breast cancer	2.66e-05	0.000109	CcSEcCtD
Mirtazapine—Pruritus—Paclitaxel—breast cancer	2.66e-05	0.000109	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—breast cancer	2.65e-05	0.000109	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—breast cancer	2.64e-05	0.000109	CcSEcCtD
Mirtazapine—Pain—Capecitabine—breast cancer	2.64e-05	0.000109	CcSEcCtD
Mirtazapine—Constipation—Capecitabine—breast cancer	2.64e-05	0.000109	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—breast cancer	2.63e-05	0.000108	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—breast cancer	2.62e-05	0.000108	CcSEcCtD
Mirtazapine—Nausea—Fluorouracil—breast cancer	2.62e-05	0.000108	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—breast cancer	2.61e-05	0.000108	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—breast cancer	2.61e-05	0.000107	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—breast cancer	2.61e-05	0.000107	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—breast cancer	2.6e-05	0.000107	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—breast cancer	2.6e-05	0.000107	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—breast cancer	2.59e-05	0.000107	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—breast cancer	2.59e-05	0.000107	CcSEcCtD
Mirtazapine—Tension—Epirubicin—breast cancer	2.58e-05	0.000106	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—breast cancer	2.58e-05	0.000106	CcSEcCtD
Mirtazapine—Diarrhoea—Paclitaxel—breast cancer	2.57e-05	0.000106	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—breast cancer	2.55e-05	0.000105	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—breast cancer	2.54e-05	0.000105	CcSEcCtD
Mirtazapine—Feeling abnormal—Capecitabine—breast cancer	2.54e-05	0.000105	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—breast cancer	2.54e-05	0.000104	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—breast cancer	2.53e-05	0.000104	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—breast cancer	2.53e-05	0.000104	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Capecitabine—breast cancer	2.52e-05	0.000104	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—breast cancer	2.52e-05	0.000104	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—breast cancer	2.52e-05	0.000104	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—breast cancer	2.52e-05	0.000104	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—breast cancer	2.51e-05	0.000103	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—breast cancer	2.5e-05	0.000103	CcSEcCtD
Mirtazapine—Dizziness—Paclitaxel—breast cancer	2.48e-05	0.000102	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—breast cancer	2.47e-05	0.000102	CcSEcCtD
Mirtazapine—Cough—Methotrexate—breast cancer	2.45e-05	0.000101	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—breast cancer	2.45e-05	0.000101	CcSEcCtD
Mirtazapine—Urticaria—Capecitabine—breast cancer	2.45e-05	0.000101	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—breast cancer	2.44e-05	0.000101	CcSEcCtD
Mirtazapine—Abdominal pain—Capecitabine—breast cancer	2.44e-05	0.0001	CcSEcCtD
Mirtazapine—Body temperature increased—Capecitabine—breast cancer	2.44e-05	0.0001	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—breast cancer	2.44e-05	0.0001	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—breast cancer	2.43e-05	0.0001	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—breast cancer	2.43e-05	0.0001	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—breast cancer	2.42e-05	9.96e-05	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—breast cancer	2.4e-05	9.88e-05	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—breast cancer	2.39e-05	9.86e-05	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—breast cancer	2.39e-05	9.86e-05	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—breast cancer	2.39e-05	9.86e-05	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—breast cancer	2.39e-05	9.84e-05	CcSEcCtD
Mirtazapine—Vomiting—Paclitaxel—breast cancer	2.39e-05	9.83e-05	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—breast cancer	2.38e-05	9.82e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.38e-05	9.79e-05	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—breast cancer	2.37e-05	9.77e-05	CcSEcCtD
Mirtazapine—Rash—Paclitaxel—breast cancer	2.37e-05	9.75e-05	CcSEcCtD
Mirtazapine—Dermatitis—Paclitaxel—breast cancer	2.37e-05	9.74e-05	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—breast cancer	2.36e-05	9.74e-05	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—breast cancer	2.36e-05	9.74e-05	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—breast cancer	2.36e-05	9.74e-05	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—breast cancer	2.36e-05	9.72e-05	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—breast cancer	2.35e-05	9.7e-05	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—breast cancer	2.35e-05	9.7e-05	CcSEcCtD
Mirtazapine—Headache—Paclitaxel—breast cancer	2.35e-05	9.69e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—breast cancer	2.34e-05	9.66e-05	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—breast cancer	2.32e-05	9.58e-05	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—breast cancer	2.31e-05	9.53e-05	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—breast cancer	2.31e-05	9.52e-05	CcSEcCtD
Mirtazapine—Cough—Epirubicin—breast cancer	2.3e-05	9.46e-05	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—breast cancer	2.28e-05	9.41e-05	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—breast cancer	2.28e-05	9.39e-05	CcSEcCtD
Mirtazapine—Infection—Methotrexate—breast cancer	2.28e-05	9.39e-05	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—breast cancer	2.27e-05	9.35e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Capecitabine—breast cancer	2.27e-05	9.35e-05	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—breast cancer	2.26e-05	9.3e-05	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—breast cancer	2.25e-05	9.28e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—breast cancer	2.25e-05	9.27e-05	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—breast cancer	2.25e-05	9.27e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—breast cancer	2.25e-05	9.25e-05	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—breast cancer	2.24e-05	9.22e-05	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—breast cancer	2.24e-05	9.22e-05	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—breast cancer	2.24e-05	9.22e-05	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—breast cancer	2.24e-05	9.21e-05	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—breast cancer	2.23e-05	9.19e-05	CcSEcCtD
Mirtazapine—Nausea—Paclitaxel—breast cancer	2.23e-05	9.19e-05	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—breast cancer	2.23e-05	9.18e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.22e-05	9.16e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—breast cancer	2.22e-05	9.14e-05	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—breast cancer	2.21e-05	9.11e-05	CcSEcCtD
Mirtazapine—Asthenia—Capecitabine—breast cancer	2.21e-05	9.11e-05	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—breast cancer	2.19e-05	9.04e-05	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—breast cancer	2.19e-05	9.02e-05	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—breast cancer	2.19e-05	9.01e-05	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—breast cancer	2.19e-05	9.01e-05	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—breast cancer	2.18e-05	8.99e-05	CcSEcCtD
Mirtazapine—Pruritus—Capecitabine—breast cancer	2.18e-05	8.98e-05	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—breast cancer	2.18e-05	8.97e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—breast cancer	2.18e-05	8.97e-05	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—breast cancer	2.16e-05	8.92e-05	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—breast cancer	2.15e-05	8.86e-05	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—breast cancer	2.15e-05	8.84e-05	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—breast cancer	2.14e-05	8.83e-05	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—breast cancer	2.14e-05	8.81e-05	CcSEcCtD
Mirtazapine—Infection—Epirubicin—breast cancer	2.13e-05	8.79e-05	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—breast cancer	2.12e-05	8.75e-05	CcSEcCtD
Mirtazapine—Shock—Epirubicin—breast cancer	2.11e-05	8.7e-05	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—breast cancer	2.11e-05	8.69e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Capecitabine—breast cancer	2.11e-05	8.69e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—breast cancer	2.11e-05	8.67e-05	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—breast cancer	2.1e-05	8.67e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—breast cancer	2.1e-05	8.66e-05	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—breast cancer	2.1e-05	8.66e-05	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—breast cancer	2.1e-05	8.63e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.09e-05	8.61e-05	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—breast cancer	2.09e-05	8.59e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—breast cancer	2.08e-05	8.55e-05	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—breast cancer	2.07e-05	8.55e-05	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—breast cancer	2.07e-05	8.54e-05	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—breast cancer	2.07e-05	8.54e-05	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—breast cancer	2.07e-05	8.54e-05	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—breast cancer	2.06e-05	8.51e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—breast cancer	2.06e-05	8.49e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.06e-05	8.48e-05	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—breast cancer	2.05e-05	8.43e-05	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—breast cancer	2.05e-05	8.43e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—breast cancer	2.05e-05	8.42e-05	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—breast cancer	2.04e-05	8.4e-05	CcSEcCtD
Mirtazapine—Dizziness—Capecitabine—breast cancer	2.04e-05	8.39e-05	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—breast cancer	2.03e-05	8.35e-05	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—breast cancer	2.02e-05	8.34e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—breast cancer	2.02e-05	8.32e-05	CcSEcCtD
Mirtazapine—Rash—Docetaxel—breast cancer	2.01e-05	8.27e-05	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—breast cancer	2.01e-05	8.26e-05	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—breast cancer	2e-05	8.26e-05	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—breast cancer	2e-05	8.25e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—breast cancer	1.99e-05	8.21e-05	CcSEcCtD
Mirtazapine—Headache—Docetaxel—breast cancer	1.99e-05	8.21e-05	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—breast cancer	1.99e-05	8.18e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—breast cancer	1.98e-05	8.16e-05	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—breast cancer	1.98e-05	8.15e-05	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—breast cancer	1.97e-05	8.13e-05	CcSEcCtD
Mirtazapine—Pain—Methotrexate—breast cancer	1.96e-05	8.08e-05	CcSEcCtD
Mirtazapine—Vomiting—Capecitabine—breast cancer	1.96e-05	8.07e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.96e-05	8.06e-05	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—breast cancer	1.95e-05	8.05e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—breast cancer	1.95e-05	8.02e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—breast cancer	1.94e-05	8.01e-05	CcSEcCtD
Mirtazapine—Rash—Capecitabine—breast cancer	1.94e-05	8e-05	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—breast cancer	1.94e-05	8e-05	CcSEcCtD
Mirtazapine—Dermatitis—Capecitabine—breast cancer	1.94e-05	8e-05	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—breast cancer	1.94e-05	7.99e-05	CcSEcCtD
Mirtazapine—Headache—Capecitabine—breast cancer	1.93e-05	7.95e-05	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—breast cancer	1.93e-05	7.95e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—breast cancer	1.93e-05	7.94e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—breast cancer	1.92e-05	7.91e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—breast cancer	1.91e-05	7.88e-05	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—breast cancer	1.91e-05	7.86e-05	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—breast cancer	1.89e-05	7.8e-05	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—breast cancer	1.89e-05	7.79e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—breast cancer	1.89e-05	7.79e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—breast cancer	1.89e-05	7.78e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—breast cancer	1.88e-05	7.73e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—breast cancer	1.87e-05	7.69e-05	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—breast cancer	1.86e-05	7.65e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—breast cancer	1.85e-05	7.63e-05	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—breast cancer	1.85e-05	7.62e-05	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—breast cancer	1.84e-05	7.56e-05	CcSEcCtD
Mirtazapine—Pain—Epirubicin—breast cancer	1.84e-05	7.56e-05	CcSEcCtD
Mirtazapine—Nausea—Capecitabine—breast cancer	1.83e-05	7.54e-05	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—breast cancer	1.82e-05	7.51e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—breast cancer	1.81e-05	7.47e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—breast cancer	1.81e-05	7.47e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.81e-05	7.45e-05	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—breast cancer	1.8e-05	7.4e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—breast cancer	1.78e-05	7.35e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—breast cancer	1.77e-05	7.29e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—breast cancer	1.77e-05	7.29e-05	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—breast cancer	1.77e-05	7.27e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—breast cancer	1.76e-05	7.23e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—breast cancer	1.75e-05	7.2e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—breast cancer	1.73e-05	7.11e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.71e-05	7.06e-05	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—breast cancer	1.71e-05	7.05e-05	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—breast cancer	1.71e-05	7.03e-05	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—breast cancer	1.7e-05	7e-05	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—breast cancer	1.7e-05	7e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—breast cancer	1.7e-05	6.99e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—breast cancer	1.7e-05	6.99e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—breast cancer	1.69e-05	6.96e-05	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—breast cancer	1.65e-05	6.78e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—breast cancer	1.64e-05	6.74e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—breast cancer	1.62e-05	6.69e-05	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—breast cancer	1.62e-05	6.69e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—breast cancer	1.58e-05	6.52e-05	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—breast cancer	1.58e-05	6.5e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—breast cancer	1.57e-05	6.47e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—breast cancer	1.57e-05	6.47e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—breast cancer	1.57e-05	6.47e-05	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—breast cancer	1.54e-05	6.34e-05	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—breast cancer	1.52e-05	6.26e-05	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—breast cancer	1.52e-05	6.25e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—breast cancer	1.47e-05	6.05e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—breast cancer	1.46e-05	6.03e-05	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—breast cancer	1.46e-05	6.01e-05	CcSEcCtD
Mirtazapine—Rash—Methotrexate—breast cancer	1.45e-05	5.96e-05	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—breast cancer	1.45e-05	5.95e-05	CcSEcCtD
Mirtazapine—Headache—Methotrexate—breast cancer	1.44e-05	5.92e-05	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—breast cancer	1.43e-05	5.87e-05	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—breast cancer	1.42e-05	5.85e-05	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—breast cancer	1.41e-05	5.79e-05	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—breast cancer	1.36e-05	5.62e-05	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—breast cancer	1.36e-05	5.61e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—breast cancer	1.36e-05	5.6e-05	CcSEcCtD
Mirtazapine—Rash—Epirubicin—breast cancer	1.35e-05	5.58e-05	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—breast cancer	1.35e-05	5.57e-05	CcSEcCtD
Mirtazapine—Headache—Epirubicin—breast cancer	1.34e-05	5.54e-05	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—breast cancer	1.31e-05	5.41e-05	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—breast cancer	1.28e-05	5.25e-05	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—breast cancer	1.26e-05	5.2e-05	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—breast cancer	1.25e-05	5.16e-05	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—breast cancer	1.25e-05	5.15e-05	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—breast cancer	1.24e-05	5.13e-05	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—breast cancer	1.18e-05	4.86e-05	CcSEcCtD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.53e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—breast cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—breast cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—breast cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—breast cancer	1.51e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—COMT—breast cancer	1.51e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—breast cancer	1.51e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.5e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—breast cancer	1.5e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.5e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—breast cancer	1.5e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—breast cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—breast cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—breast cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—breast cancer	1.49e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HMOX1—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ITPR1—breast cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.46e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—breast cancer	1.46e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—breast cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAV1—breast cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.45e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—breast cancer	1.45e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—breast cancer	1.45e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.45e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.45e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.44e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.44e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—breast cancer	1.44e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—breast cancer	1.44e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.44e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.44e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—breast cancer	1.43e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.42e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—breast cancer	1.42e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.42e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.42e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—breast cancer	1.41e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.41e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—breast cancer	1.41e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.4e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—breast cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—breast cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.39e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NCOR1—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.38e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—breast cancer	1.38e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.38e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—breast cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.37e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.37e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—breast cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—breast cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—breast cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—breast cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—breast cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—breast cancer	1.35e-06	1.12e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—breast cancer	1.35e-06	1.12e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.34e-06	1.12e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—breast cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.33e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.33e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.33e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—breast cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—breast cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—breast cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.32e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX1—breast cancer	1.32e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.32e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—breast cancer	1.32e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.31e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.31e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—breast cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—breast cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—NOS3—breast cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—breast cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ERCC2—breast cancer	1.3e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.29e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.29e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—NOS3—breast cancer	1.29e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.28e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.27e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—breast cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—breast cancer	1.26e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—breast cancer	1.26e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.26e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.25e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.25e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.25e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—breast cancer	1.24e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.23e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.23e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.22e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	1.22e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—breast cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—breast cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—breast cancer	1.21e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—breast cancer	1.21e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.21e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.21e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—breast cancer	1.21e-06	1e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—breast cancer	1.21e-06	1e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—breast cancer	1.2e-06	1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.2e-06	9.99e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.2e-06	9.97e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.2e-06	9.93e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—breast cancer	1.19e-06	9.89e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.19e-06	9.89e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.19e-06	9.89e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—breast cancer	1.19e-06	9.88e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—breast cancer	1.19e-06	9.88e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.19e-06	9.88e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.19e-06	9.87e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—breast cancer	1.19e-06	9.86e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—breast cancer	1.18e-06	9.82e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—breast cancer	1.18e-06	9.8e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.17e-06	9.69e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.17e-06	9.67e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.16e-06	9.6e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—breast cancer	1.16e-06	9.6e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—breast cancer	1.16e-06	9.6e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—breast cancer	1.15e-06	9.57e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—breast cancer	1.15e-06	9.55e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—breast cancer	1.14e-06	9.49e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.14e-06	9.45e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—breast cancer	1.13e-06	9.39e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—breast cancer	1.13e-06	9.38e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAV1—breast cancer	1.13e-06	9.34e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—breast cancer	1.12e-06	9.33e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—breast cancer	1.12e-06	9.33e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—breast cancer	1.12e-06	9.31e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—breast cancer	1.12e-06	9.3e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—breast cancer	1.12e-06	9.29e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—breast cancer	1.11e-06	9.19e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—breast cancer	1.11e-06	9.19e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—breast cancer	1.11e-06	9.18e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.1e-06	9.17e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NOS3—breast cancer	1.1e-06	9.15e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.1e-06	9.14e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—breast cancer	1.1e-06	9.14e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—breast cancer	1.08e-06	8.99e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.08e-06	8.99e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.07e-06	8.89e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—breast cancer	1.06e-06	8.79e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—breast cancer	1.05e-06	8.74e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.05e-06	8.72e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—breast cancer	1.04e-06	8.62e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	8.58e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	8.56e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—breast cancer	1.03e-06	8.54e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.02e-06	8.51e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—breast cancer	1.02e-06	8.51e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.02e-06	8.49e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—breast cancer	1.02e-06	8.48e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.02e-06	8.45e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—breast cancer	1.02e-06	8.43e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.01e-06	8.4e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—breast cancer	1.01e-06	8.37e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—breast cancer	9.99e-07	8.3e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—breast cancer	9.99e-07	8.29e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—breast cancer	9.97e-07	8.28e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—breast cancer	9.78e-07	8.12e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—breast cancer	9.76e-07	8.11e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—breast cancer	9.71e-07	8.07e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—breast cancer	9.71e-07	8.06e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—breast cancer	9.55e-07	7.93e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—breast cancer	9.53e-07	7.92e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—breast cancer	9.45e-07	7.85e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	9.39e-07	7.8e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—breast cancer	9.35e-07	7.77e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—breast cancer	9.29e-07	7.72e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—breast cancer	9.18e-07	7.62e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—breast cancer	9.14e-07	7.59e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—breast cancer	9.12e-07	7.58e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—breast cancer	9.09e-07	7.55e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—breast cancer	9.01e-07	7.48e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—breast cancer	8.95e-07	7.44e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—breast cancer	8.92e-07	7.41e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—breast cancer	8.89e-07	7.38e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—breast cancer	8.79e-07	7.3e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—breast cancer	8.69e-07	7.22e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—breast cancer	8.57e-07	7.12e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NOS3—breast cancer	8.51e-07	7.06e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—breast cancer	8.44e-07	7.01e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—breast cancer	8.42e-07	6.99e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—breast cancer	8.32e-07	6.91e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—breast cancer	8.26e-07	6.86e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—breast cancer	7.85e-07	6.52e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—breast cancer	7.78e-07	6.46e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—breast cancer	7.67e-07	6.37e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.32e-07	6.08e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—breast cancer	7.29e-07	6.05e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—breast cancer	7.26e-07	6.03e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—breast cancer	6.79e-07	5.63e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—breast cancer	6.2e-07	5.15e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—breast cancer	5.98e-07	4.97e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—breast cancer	5.93e-07	4.92e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—breast cancer	5.07e-07	4.21e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—breast cancer	4.79e-07	3.97e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—breast cancer	3.91e-07	3.25e-06	CbGpPWpGaD
